CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Grant or award Director acquired 701 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 334 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 534 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 444 shares (to pay taxes)
- 4 Gift Chief Executive Officer gave 2,000 shares (gift)
- 4 Grant or award Director acquired 92 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Senior VP, R&D sold 3,517 shares at $193.73 ($681,348)
- 4 Planned sale Chief Executive Officer sold 16,707 shares at an average $197.44 ($3,298,632)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,867 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 386 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,206 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 386 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 8,386 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 131 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 219 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 135 shares (to pay taxes)
- 4 Grant or award Chief Operating Officer acquired 50 shares (grant or award)
- 4 Shares withheld for taxes Senior VP, R&D gave up 453 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,322 shares (to pay taxes)
Page 6 of 34 · 669 filings